Adenosine A2A receptor agonist
This page covers all Adenosine A2A receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adenosine A2A receptor.
Targets
Marketed (3)
- Regadenoson myocardial perfusion imaging · University of Colorado, Denver · Cardiovascular
Regadenoson is a selective adenosine A2A receptor agonist that increases coronary blood flow to detect areas of reduced perfusion during cardiac imaging. - Regadenoson (Lexiscan) · Brigham and Women's Hospital · Cardiovascular
Regadenoson is a selective adenosine A2A receptor agonist that increases coronary blood flow to induce cardiac stress for diagnostic imaging. - Regadenoson MRI myocardial blood flow · University of Colorado, Denver · Cardiovascular
Regadenoson is a selective adenosine A2A receptor agonist that increases coronary blood flow to enable assessment of myocardial perfusion during cardiac MRI imaging.
Phase 3 pipeline (2)
- Regadenoson peripheral - peripheral · Lokien van Nunen · Cardiovascular
Regadenoson is an adenosine A2A receptor agonist that causes peripheral vasodilation to increase blood flow, used as a pharmacologic stress agent for cardiac imaging. - Regadenoson peripheral - central · Lokien van Nunen · Cardiovascular
Regadenoson is an adenosine A2A receptor agonist that causes coronary vasodilation to increase blood flow, used for cardiac stress testing.